Nanox Appoints Gilad Yron as Chief Business Officer
September 10, 2020
Nanox to Participate in Two Upcoming Investor Conferences
September 9, 2020
Nanox Signs Agreement With SPI Medical to Deploy 630 Nanox.ARC Units in Mexico
August 25, 2020
Nanox Announces Closing of Initial Public Offering
August 21, 2020
Nanox Announces Pricing of Upsized Initial Public Offering
July 28, 2020
Nanox Exceeds $100M Crossover Investment
June 25, 2020
Nanox Signs Strategic Agreement With Golden Vine to Deploy 500 Nanox.ARC Systems in Taiwan and Singapore
June 15, 2020
Nanox Signs $48 Million Agreement in Russia and Belarus for Nanox.ARC Medical Imaging Services
June 8, 2020
Nanox Signs Agreement With Promedica to Deploy 500 Nanox.ARC Units in Italy
June 4, 2020
SK Telecom Invests an Additional $20 Million in Nanox
April 27, 2020
Nanox Signs Agreement with Hadassah Medical Organization to develop Novel Early-Detection Protocols for Nanox.ARC
April 7, 2020
Nanox Partners With Qure.ai to Integrate its AI-based Medical Imaging Solutions into Nanox.CLOUD
March 25, 2020
Nanox Announces Agreement with CureMetrix for AI-based Assistive Diagnostic Tool to Support Nanox.Cloud
March 2, 2020
Nanox Signs Agreement With The Gateway Group for the Deployment of 1,000 Nanox.ARC Units Across Australia, New Zealand, and Norway
February 6, 2020
Nanox Signs Strategic Collaboration Agreement With USARAD for the Deployment of 3,000 Nanox Systems in the U.S.
January 16, 2020
Nanox Secures $26M Supported by Strategic Investment From Foxconn, Unveiling the Nanox System
November 19, 2019
Nanox Introduces Digital X-ray Source Technology
If you are a medical imaging system vendor, a radiology association representative, a medical diagnostics AI company, a government agency, a healthcare disruption enterprise.... contact us. We have a lot to talk about.
We welcome anyone who supports the nanox.vision and believes they can contribute to this cause.
Thank you! Your submission has been received!
Something went wrong while submitting the form. Kindly try again later.